Find insights on China’s healthcare sector, Thomson Medical Group, Cochlear, and more in the latest Market Talks covering the ...

A PAT roadmap should address data analysis, aggregation, visualization, and the smart utility of those data for greater process understanding.

Asian equities were mostly higher overnight as Mainland China and Hong Kong outperformed and Indonesia and Thailand ...

WuXi AppTec Co. and WuXi Biologics Cayman Inc. said they see a brighter 2025 for the Chinese biotech and drug companies after the US Biosecure legislation that threatened to cut them out from ...

WuXi Biologics' CEO Chris Chen has denied that the company’s sale of its less than four-year-old Ireland site is due to the threat of the US Biosecure Act, and said that the number of new ...

WuXi Biologics agreed to sell an overseas vaccine ... will improve Biologics' overall profitability." The shakeup in the AI space has spread waves across the stock market. Here’s what investors ...

SHANGHAI, Feb. 10, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it has been ...

MSD has expanded its presence in Ireland with an agreement to buy a vaccine manufacturing facility from Chinese biotech WuXi Biologics for around €500 million (around $520 million). The plant in ...

WuXi Biologics ranks in the top 1% of companies assessed in the pharmaceutical industry. In recent years, WuXi Biologics' ESG strategy and initiatives have made significant progress and gained ...